CRISPR-based strategies for studying regulatory elements and chromatin structure in mammalian gene control

Cia Hin Lau, Yousin Suh

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The development of high-throughput methods has enabled the genome-wide identification of putative regulatory elements in a wide variety of mammalian cells at an unprecedented resolution. Extensive genomic studies have revealed the important role of regulatory elements and genetic variation therein in disease formation and risk. In most cases, there is only correlative evidence for the roles of these elements and non-coding changes within these elements in pathogenesis. With the advent of genome- and epigenome-editing tools based on the CRISPR technology, it is now possible to test the functional relevance of the regulatory elements and alterations on a genomic scale. Here, we review the various CRISPR-based strategies that have been developed to functionally validate the candidate regulatory elements in mammals as well as the non-coding genetic variants found to be associated with human disease. We also discuss how these synthetic biology tools have helped to elucidate the role of three-dimensional nuclear architecture and higher-order chromatin organization in shaping functional genome and controlling gene expression.

Original languageEnglish (US)
Pages (from-to)1-24
Number of pages24
JournalMammalian Genome
DOIs
StateAccepted/In press - Dec 1 2017

Fingerprint

Clustered Regularly Interspaced Short Palindromic Repeats
Chromatin
Genome
Synthetic Biology
Genes
Mammals
Technology
Gene Expression

ASJC Scopus subject areas

  • Genetics

Cite this

CRISPR-based strategies for studying regulatory elements and chromatin structure in mammalian gene control. / Lau, Cia Hin; Suh, Yousin.

In: Mammalian Genome, 01.12.2017, p. 1-24.

Research output: Contribution to journalArticle

@article{c0957ff1cb8d4ef088b7396b08d94253,
title = "CRISPR-based strategies for studying regulatory elements and chromatin structure in mammalian gene control",
abstract = "The development of high-throughput methods has enabled the genome-wide identification of putative regulatory elements in a wide variety of mammalian cells at an unprecedented resolution. Extensive genomic studies have revealed the important role of regulatory elements and genetic variation therein in disease formation and risk. In most cases, there is only correlative evidence for the roles of these elements and non-coding changes within these elements in pathogenesis. With the advent of genome- and epigenome-editing tools based on the CRISPR technology, it is now possible to test the functional relevance of the regulatory elements and alterations on a genomic scale. Here, we review the various CRISPR-based strategies that have been developed to functionally validate the candidate regulatory elements in mammals as well as the non-coding genetic variants found to be associated with human disease. We also discuss how these synthetic biology tools have helped to elucidate the role of three-dimensional nuclear architecture and higher-order chromatin organization in shaping functional genome and controlling gene expression.",
author = "Lau, {Cia Hin} and Yousin Suh",
year = "2017",
month = "12",
day = "1",
doi = "10.1007/s00335-017-9727-2",
language = "English (US)",
pages = "1--24",
journal = "Mammalian Genome",
issn = "0938-8990",
publisher = "Springer New York",

}

TY - JOUR

T1 - CRISPR-based strategies for studying regulatory elements and chromatin structure in mammalian gene control

AU - Lau, Cia Hin

AU - Suh, Yousin

PY - 2017/12/1

Y1 - 2017/12/1

N2 - The development of high-throughput methods has enabled the genome-wide identification of putative regulatory elements in a wide variety of mammalian cells at an unprecedented resolution. Extensive genomic studies have revealed the important role of regulatory elements and genetic variation therein in disease formation and risk. In most cases, there is only correlative evidence for the roles of these elements and non-coding changes within these elements in pathogenesis. With the advent of genome- and epigenome-editing tools based on the CRISPR technology, it is now possible to test the functional relevance of the regulatory elements and alterations on a genomic scale. Here, we review the various CRISPR-based strategies that have been developed to functionally validate the candidate regulatory elements in mammals as well as the non-coding genetic variants found to be associated with human disease. We also discuss how these synthetic biology tools have helped to elucidate the role of three-dimensional nuclear architecture and higher-order chromatin organization in shaping functional genome and controlling gene expression.

AB - The development of high-throughput methods has enabled the genome-wide identification of putative regulatory elements in a wide variety of mammalian cells at an unprecedented resolution. Extensive genomic studies have revealed the important role of regulatory elements and genetic variation therein in disease formation and risk. In most cases, there is only correlative evidence for the roles of these elements and non-coding changes within these elements in pathogenesis. With the advent of genome- and epigenome-editing tools based on the CRISPR technology, it is now possible to test the functional relevance of the regulatory elements and alterations on a genomic scale. Here, we review the various CRISPR-based strategies that have been developed to functionally validate the candidate regulatory elements in mammals as well as the non-coding genetic variants found to be associated with human disease. We also discuss how these synthetic biology tools have helped to elucidate the role of three-dimensional nuclear architecture and higher-order chromatin organization in shaping functional genome and controlling gene expression.

UR - http://www.scopus.com/inward/record.url?scp=85035785629&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85035785629&partnerID=8YFLogxK

U2 - 10.1007/s00335-017-9727-2

DO - 10.1007/s00335-017-9727-2

M3 - Article

SP - 1

EP - 24

JO - Mammalian Genome

JF - Mammalian Genome

SN - 0938-8990

ER -